-
公开(公告)号:US20100292468A1
公开(公告)日:2010-11-18
申请号:US12739434
申请日:2008-10-24
申请人: Srinivasan Babu , Zhigang Cheng , Mark E. Reynolds , Scott J. Savage , Qingping Tian , Herbert Yajima
发明人: Srinivasan Babu , Zhigang Cheng , Mark E. Reynolds , Scott J. Savage , Qingping Tian , Herbert Yajima
IPC分类号: C07D495/04 , C07F5/02 , C07D405/04
CPC分类号: C07D513/04 , C07D405/04 , C07D495/04 , C07F5/025
摘要: The invention provides processes of preparing, separating, and purifying PI3K inhibitor, Formula (I) and (II) compounds, and novel intermediates for preparing Formula (I) and (II) compounds.
摘要翻译: 本发明提供制备,分离和纯化PI3K抑制剂,式(I)和(II)化合物的方法,以及制备式(I)和(II)化合物的新型中间体。
-
公开(公告)号:US08354528B2
公开(公告)日:2013-01-15
申请号:US12739434
申请日:2008-10-24
申请人: Srinivasan Babu , Zhigang Cheng , Mark E. Reynolds , Scott J. Savage , Qingping Tian , Herbert Yajima
发明人: Srinivasan Babu , Zhigang Cheng , Mark E. Reynolds , Scott J. Savage , Qingping Tian , Herbert Yajima
IPC分类号: C07D413/14
CPC分类号: C07D513/04 , C07D405/04 , C07D495/04 , C07F5/025
摘要: The invention provides processes of preparing, separating, and purifying PI3K inhibitor, Formula (I) and (II) compounds, and novel intermediates for preparing Formula (I) and (II) compounds.
摘要翻译: 本发明提供制备,分离和纯化PI3K抑制剂,式(I)和(II)化合物的方法,以及制备式(I)和(II)化合物的新型中间体。
-
公开(公告)号:US07888364B2
公开(公告)日:2011-02-15
申请号:US11217663
申请日:2005-09-02
申请人: Janet L. Gunzner , Daniel Sutherlin , Mark S. Stanley , Liang Bao , Georgette M. Castanedo , Rebecca L. Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina
发明人: Janet L. Gunzner , Daniel Sutherlin , Mark S. Stanley , Liang Bao , Georgette M. Castanedo , Rebecca L. Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina
IPC分类号: C07D403/02 , A61K31/4439
CPC分类号: C07D213/16 , C07D213/38 , C07D213/40 , C07D213/56 , C07D213/70 , C07D213/75 , C07D213/81 , C07D213/82 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/04 , C07D417/12 , C07F9/58
摘要: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.
摘要翻译: 本发明提供了可用作治疗恶性肿瘤的治疗剂的刺猬蛋白信号传导的新型抑制剂,其中化合物具有通式I:其中A,X,Y R1,R2,R3,R4,m和n如本文所述。
-
公开(公告)号:US20120094980A1
公开(公告)日:2012-04-19
申请号:US13273945
申请日:2011-10-14
申请人: Janet L. Gunzner , Daniel P. Sutherlin , Mark S. Stanley , Liang Bao , Georgette Castanedo , Rebecca Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina , Michael F.T. Koehler
发明人: Janet L. Gunzner , Daniel P. Sutherlin , Mark S. Stanley , Liang Bao , Georgette Castanedo , Rebecca Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina , Michael F.T. Koehler
IPC分类号: A61K31/551 , A61K31/5377 , C07D401/14 , A61K31/444 , C07D213/56 , A61K31/44 , C07D409/12 , A61K31/4436 , C07D413/12 , A61K31/4439 , C07D403/14 , A61K31/496 , C07D401/12 , A61K31/506 , C07D417/12 , A61K31/541 , A61K31/4545 , C12N5/07 , A61P35/00 , A61P9/00 , C07D413/14
CPC分类号: C07D213/16 , C07D213/06 , C07D213/56 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07F9/58
摘要: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.
摘要翻译: 本发明提供了可用作治疗恶性肿瘤的治疗剂的刺猬蛋白信号传导的新型抑制剂,其中化合物具有通式I:其中A,X,Y R1,R2,R3,R4,m和n如本文所述。
-
公开(公告)号:US20090281089A1
公开(公告)日:2009-11-12
申请号:US12420746
申请日:2009-04-08
申请人: Janet L. Gunzner , Daniel P. Sutherlin , Mark S. Stanley , Liang Bao , Georgette Castanedo , Rebecca L. LaLonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina
发明人: Janet L. Gunzner , Daniel P. Sutherlin , Mark S. Stanley , Liang Bao , Georgette Castanedo , Rebecca L. LaLonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina
IPC分类号: A61K31/444 , C07D413/14 , C07D401/14 , C07D213/56 , C07D417/12 , C07D413/12 , C07D401/12 , A61P35/00 , A61K31/5377 , A61K31/4402 , A61K31/496 , A61K31/541 , A61K31/4439 , A61K31/506 , A61K31/551
CPC分类号: C07D213/16 , C07D213/06 , C07D213/56 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07F9/58
摘要: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.
摘要翻译: 本发明提供了可用作治疗恶性肿瘤的治疗剂的刺猬蛋白信号传导的新型抑制剂,其中化合物具有通式I:其中A,X,Y R1,R2,R3,R4,m和n如本文所述。
-
公开(公告)号:US09278961B2
公开(公告)日:2016-03-08
申请号:US12960609
申请日:2010-12-06
申请人: Janet L. Gunzner , Daniel Sutherlin , Mark S. Stanley , Liang Bao , Georgette M. Castanedo , Rebecca L. Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina , Michael F. T. Koehler
发明人: Janet L. Gunzner , Daniel Sutherlin , Mark S. Stanley , Liang Bao , Georgette M. Castanedo , Rebecca L. Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina , Michael F. T. Koehler
IPC分类号: C07D213/38 , C07D417/12 , C07D401/14 , A61K31/44 , C07D213/40 , C07D213/56 , C07D213/70 , C07D213/75 , C07D213/81 , C07D213/82 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/04 , C07F9/58
CPC分类号: C07D213/16 , C07D213/38 , C07D213/40 , C07D213/56 , C07D213/70 , C07D213/75 , C07D213/81 , C07D213/82 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/04 , C07D417/12 , C07F9/58
摘要: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.
-
公开(公告)号:US20110092461A1
公开(公告)日:2011-04-21
申请号:US12960609
申请日:2010-12-06
申请人: Janet L. GUNZNER , Daniel Sutherlin , Mark S. Stanley , Liang Bao , Georgette M. Castanedo , Rebecca L. Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina
发明人: Janet L. GUNZNER , Daniel Sutherlin , Mark S. Stanley , Liang Bao , Georgette M. Castanedo , Rebecca L. Lalonde , Shumei Wang , Mark E. Reynolds , Scott J. Savage , Kimberly Malesky , Michael S. Dina
IPC分类号: A61K31/675 , C07D413/12 , C07D401/14 , C07D213/56 , C07D409/12 , C07D401/12 , C07D413/14 , C07D417/12 , A61K31/5377 , A61K31/444 , A61K31/4418 , A61K31/4436 , A61K31/4439 , A61K31/496 , A61K31/506 , A61K31/541 , A61K31/551 , C12N5/071 , A61P35/00
CPC分类号: C07D213/16 , C07D213/38 , C07D213/40 , C07D213/56 , C07D213/70 , C07D213/75 , C07D213/81 , C07D213/82 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/04 , C07D417/12 , C07F9/58
摘要: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.
摘要翻译: 本发明提供了可用作治疗恶性肿瘤的治疗剂的刺猬蛋白信号传导的新型抑制剂,其中化合物具有通式I:其中A,X,Y R1,R2,R3,R4,m和n如本文所述。
-
-
-
-
-
-